Sort
261,768 grants matching “gene therapy”
Long-Term Neural Determinants of Cardiovascular Diseases
$1,108,229John W Osborn · University Of Minnesota · R01 · FY2006 · HL
Stem cell-based modeling of type 1 diabetes to accelerate translation of therapies
$1,108,154Audrey Parent · University Of California, San Francisco · UG3 · FY2025 · DK
TrkB.T1 as a Genetic Disease Modifier of Muscular Dystrophy
$1,108,102Susan G Dorsey · University Of Maryland Baltimore · RC2 · FY2009 · NR
Clinical Trials with Immunotoxins
$1,108,096Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
An immune-based approach for HIV eradication
$1,108,021Juan Lama · Retrovirox, Inc. · R44 · FY2015 · AI
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,107,978Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,107,849Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,107,849Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Combating resistant superbugs by understanding the molecular determinants of target site penetration and binding
$1,107,656Jurgen Bernd Bulitta · University Of Florida · R01 · FY2021 · AI
Genes contributing to nicotine dependence in humans
$1,107,615Kari Stefansson · Decode Genetics, Inc. · R01 · FY2007 · DA
Host Defense Regulation and Viral Oncogenesis
$1,107,550Glen N. Barber · University Of Miami School Of Medicine · P01 · FY2011 · CA
Germline modifiers of tumor progression and metastasis in prostate cancer
$1,107,427Nigel Crawford · National Human Genome Research Institute · ZIA · FY2016 · HG
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,107,409Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Genetics, Natural History, and Pathophysiology of Behcet's Disease
$1,107,395Daniel Kastner · National Human Genome Research Institute · ZIA · FY2015 · HG
Nonhuman Primate
$1,107,161Michael K Axthelm · Oregon Health & Science University · P01 · FY2015 · AI
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$1,107,095Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
NRG Oncology Network Group Operations Center
$1,106,894Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2024 · CA
An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer.
$1,106,781William Valentine Williams · Briacell Therapeutics Corp · R44 · FY2025 · CA
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Disease
$1,106,775Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · P30 · FY2011 · DK
The Colon Cancer Family Registry: Ontario
$1,106,753Steven Gallinger · Cancer Care Ontario · U24 · FY2009 · CA
The Hepato/Renal Fibrocystic Disease Core Center
$1,106,739Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2016 · DK
Clinical and translational studies of RUNX1 and FPDMM
$1,106,669Paul Liu · National Human Genome Research Institute · ZIA · FY2021 · HG
Molecular Profiling of Patients Undergoing Radiotherapy
$1,106,642Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
$1,106,638Thomas E Rohan · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · CA